NYSE:MCKHealthcare
Is Wider Rapiblyk Access Deepening McKesson’s Specialty Edge Or Just Incremental Volume For MCK?
AOP Health US, LLC recently announced that its critical care beta-blocker Rapiblyk (landiolol) is now broadly available across the United States through major distributors, including McKesson Corporation, giving hospitals and health systems easier access via their preferred purchasing channels.
This wider distribution highlights McKesson’s role as a key partner in specialty and critical care therapies, reinforcing its position in higher-value pharmaceutical distribution services.
With...